KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 128 filers reported holding KYMERA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,262,350 | -59.1% | 162,759 | -32.4% | 0.00% | -50.0% |
| Q2 2023 | $5,534,060 | +0.8% | 240,716 | +29.9% | 0.00% | 0.0% |
| Q1 2023 | $5,490,290 | +8.5% | 185,295 | -8.6% | 0.00% | 0.0% |
| Q4 2022 | $5,060,914 | +367.7% | 202,761 | +308.1% | 0.00% | – |
| Q3 2022 | $1,082,000 | -50.7% | 49,685 | -55.4% | 0.00% | -100.0% |
| Q2 2022 | $2,194,000 | -61.9% | 111,469 | -18.1% | 0.00% | -50.0% |
| Q1 2022 | $5,759,000 | +31.2% | 136,090 | +96.9% | 0.00% | +100.0% |
| Q4 2021 | $4,388,000 | +464.0% | 69,116 | +421.9% | 0.00% | – |
| Q3 2021 | $778,000 | -39.5% | 13,243 | -50.1% | 0.00% | – |
| Q2 2021 | $1,287,000 | +30.1% | 26,540 | +4.3% | 0.00% | – |
| Q1 2021 | $989,000 | +341.5% | 25,442 | +604.2% | 0.00% | – |
| Q4 2020 | $224,000 | +3100.0% | 3,613 | +1464.1% | 0.00% | – |
| Q3 2020 | $7,000 | – | 231 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer IX & Co. Ltd. | 1,755,356 | $97,949,000 | 48.97% |
| Trustees of Columbia University in the City of New York | 463,298 | $28,724,000 | 38.38% |
| AJU IB Investment Co., Ltd. | 704,059 | $43,652,000 | 16.52% |
| BVF INC/IL | 2,630,658 | $163,101,000 | 6.42% |
| Redmile Group, LLC | 2,720,489 | $168,670,000 | 2.04% |
| Bain Capital Life Sciences Investors, LLC | 479,605 | $29,735,000 | 1.87% |
| Rock Springs Capital Management LP | 713,865 | $44,260,000 | 0.94% |
| SPHERA FUNDS MANAGEMENT LTD. | 147,700 | $9,157,000 | 0.81% |
| HighVista Strategies LLC | 17,117 | $1,061,000 | 0.68% |
| Logos Global Management LP | 110,920 | $6,877,000 | 0.59% |